Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor
 
Sponsors and Collaborators
 
Contact
June Kryk, R.N.
(301) 451-1929
 
Investigator
James C Yang, M.D.
(301) 496-1574
National Cancer Institute (NCI)
 
ClinicalTrials.gov Identifier